News
- Author:
- Victoria Stern, MA
Publish date: August 2, 2024
This T-cell receptor therapy modifies existing receptors to recognize an array of antigens on the surface of cancer cells.
News
- Author:
- Victoria Stern, MA
Publish date: July 7, 2023
The growing administrative - and emotional - burden of prior authorization is contributing to physician burnout.
News
- Author:
- Victoria Stern, MA
Publish date: May 18, 2023
“This is an example of a process that has run so far amok. It’s just a burden across the board.”
News
- Author:
- Victoria Stern, MA
Publish date: August 23, 2022
A 2021 study found the rate of maternal mortality was almost two times higher in states that restricted abortion access compared with those that pr...
News
- Author:
- Victoria Stern, MA
Publish date: June 23, 2022
Although most oncology drugs don’t incur substantial waste, even small volumes can translate to millions of dollars a year.
News
- Author:
- Victoria Stern, MA
Publish date: February 15, 2022
The restricted supply of COVID-19 treatments has led many oncologists to create carefully curated lists of their ...
News
- Author:
- Victoria Stern, MA
Publish date: December 11, 2021
“The fact that we’re now talking about fourth- and fifth-line therapies for HER2-positive MBC represents a major advance in the managemen...
News
- Author:
- Victoria Stern, MA
Publish date: November 7, 2021
Liquid biopsies — blood analyses that allow oncologists to detect circulating tumor cells and circulating tumor DNA in the blood — are increas...
News
- Author:
- Victoria Stern, MA
Publish date: October 6, 2021
Defining a breast tumor can be tricky because these cancers often don’t fit neatly into predefined categories.
News
- Author:
- Victoria Stern, MA
Publish date: June 17, 2021
Because our systemic therapies in breast cancer are Read More
News
- Author:
- Victoria Stern, MA
Publish date: May 25, 2021
In a 12-month window, the FDA approved four agents targeting HER2-positive MBC.
News
- Author:
- Victoria Stern, MA
Publish date: February 26, 2021
Patients with metastatic breast cancer (MBC) face an elevated risk of Read More
News
- Author:
- Victoria Stern, MA
Publish date: December 23, 2020
The expert recommendations are divided into three main categories: patients who are newly diagnosed with CLL but ...
